• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分泌组分析鉴定乳腺癌浸润的驱动因素:对 CTGF 信号的深入了解。

Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling.

机构信息

Department of Gynecology and Obstetrics, University Medicine Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

Institute of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.

出版信息

Sci Rep. 2020 Oct 21;10(1):17889. doi: 10.1038/s41598-020-74838-8.

DOI:10.1038/s41598-020-74838-8
PMID:33087801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7578015/
Abstract

An altered consistency of tumor microenvironment facilitates the progression of the tumor towards metastasis. Here we combine data from secretome and proteome analysis using mass spectrometry with microarray data from mesenchymal transformed breast cancer cells (MCF-7-EMT) to elucidate the drivers of epithelial-mesenchymal transition (EMT) and cell invasion. Suppression of connective tissue growth factor (CTGF) reduced invasion in 2D and 3D invasion assays and expression of transforming growth factor-beta-induced protein ig-h3 (TGFBI), Zinc finger E-box-binding homeobox 1 (ZEB1) and lysyl oxidase (LOX), while the adhesion of cell-extracellular matrix (ECM) in mesenchymal transformed breast cancer cells is increased. In contrast, an enhanced expression of CTGF leads to an increased 3D invasion, expression of fibronectin 1 (FN1), secreted protein acidic and cysteine rich (SPARC) and CD44 and a reduced cell ECM adhesion. Gonadotropin-releasing hormone (GnRH) agonist Triptorelin reduces CTGF expression in a Ras homolog family member A (RhoA)-dependent manner. Our results suggest that CTGF drives breast cancer cell invasion in vitro and therefore could be an attractive therapeutic target for drug development to prevent the spread of breast cancer.

摘要

肿瘤微环境的改变促进了肿瘤向转移的发展。在这里,我们将使用质谱法进行的分泌组和蛋白质组分析的数据与间充质转化的乳腺癌细胞(MCF-7-EMT)的微阵列数据相结合,以阐明上皮-间充质转化(EMT)和细胞侵袭的驱动因素。结缔组织生长因子(CTGF)的抑制作用降低了 2D 和 3D 侵袭实验中的侵袭,并且表达转化生长因子-β诱导的蛋白 ig-h3(TGFBI)、锌指 E-框结合同源盒 1(ZEB1)和赖氨酰氧化酶(LOX),而间充质转化的乳腺癌细胞中细胞-细胞外基质(ECM)的粘附增加。相比之下,CTGF 的增强表达导致 3D 侵袭增加、纤维连接蛋白 1(FN1)、富含酸性和半胱氨酸的分泌蛋白(SPARC)和 CD44 的表达增加,以及细胞 ECM 粘附减少。促性腺激素释放激素(GnRH)激动剂曲普瑞林以 Ras 同源家族成员 A(RhoA)依赖性方式降低 CTGF 的表达。我们的结果表明,CTGF 驱动体外乳腺癌细胞侵袭,因此可能成为开发药物以防止乳腺癌扩散的有吸引力的治疗靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/0d21e721f91f/41598_2020_74838_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/a006da540b50/41598_2020_74838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/aa3395f2328c/41598_2020_74838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/061f28e9de4c/41598_2020_74838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/d1908a9ba9d3/41598_2020_74838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/d8bf41dc89ed/41598_2020_74838_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/7f219494e4bd/41598_2020_74838_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/83b6071a8427/41598_2020_74838_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/0d21e721f91f/41598_2020_74838_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/a006da540b50/41598_2020_74838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/aa3395f2328c/41598_2020_74838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/061f28e9de4c/41598_2020_74838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/d1908a9ba9d3/41598_2020_74838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/d8bf41dc89ed/41598_2020_74838_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/7f219494e4bd/41598_2020_74838_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/83b6071a8427/41598_2020_74838_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8210/7578015/0d21e721f91f/41598_2020_74838_Fig8_HTML.jpg

相似文献

1
Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling.通过分泌组分析鉴定乳腺癌浸润的驱动因素:对 CTGF 信号的深入了解。
Sci Rep. 2020 Oct 21;10(1):17889. doi: 10.1038/s41598-020-74838-8.
2
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.ZEB1驱动肺癌中的上皮-间质转化。
J Clin Invest. 2016 Sep 1;126(9):3219-35. doi: 10.1172/JCI76725. Epub 2016 Aug 8.
3
Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling.叉头框蛋白F1通过上调赖氨酰氧化酶并抑制Smad2/3信号传导来促进乳腺癌细胞迁移。
BMC Cancer. 2016 Feb 23;16:142. doi: 10.1186/s12885-016-2196-2.
4
Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition.上皮来源的结缔组织生长因子通过诱导上皮-间质转化和I型胶原纤维沉积促进乳腺肿瘤进展。
Oncotarget. 2015 Sep 22;6(28):25320-38. doi: 10.18632/oncotarget.4659.
5
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.miR-448 通过直接靶向 E-钙黏蛋白抑制因子 ZEB1/2 抑制乳腺癌细胞的上皮-间充质转化。
Exp Biol Med (Maywood). 2018 Mar;243(5):473-480. doi: 10.1177/1535370218754848. Epub 2018 Jan 25.
6
The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.微小RNA-200/Zeb1轴通过CRKL调节依赖细胞外基质的β1整合素/黏着斑激酶信号传导、癌细胞侵袭和转移。
Sci Rep. 2016 Jan 5;6:18652. doi: 10.1038/srep18652.
7
TGF-β2 induces transdifferentiation and fibrosis in human lens epithelial cells via regulating gremlin and CTGF.TGF-β2 通过调节 Gremlin 和 CTGF 诱导人晶状体上皮细胞转分化和纤维化。
Biochem Biophys Res Commun. 2014 May 16;447(4):689-95. doi: 10.1016/j.bbrc.2014.04.068. Epub 2014 Apr 19.
8
MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.miRNA-455-3p 通过抑制 TGF-β 信号通路介导 GATA3 在乳腺上皮细胞中的抑瘤作用。
J Biol Chem. 2019 Oct 25;294(43):15808-15825. doi: 10.1074/jbc.RA119.010800. Epub 2019 Sep 6.
9
Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.在乳腺癌中TGFβ/纤连蛋白诱导的上皮-间质转化过程中PEAK1/ZEB1信号轴的鉴定
Biochem Biophys Res Commun. 2015 Sep 25;465(3):606-12. doi: 10.1016/j.bbrc.2015.08.071. Epub 2015 Aug 20.
10
Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.源自高转移性人乳腺癌的细胞外基质通过αvβ3 整联蛋白触发上皮性乳腺癌细胞的上皮-间充质转化。
Int J Mol Sci. 2020 Apr 23;21(8):2995. doi: 10.3390/ijms21082995.

引用本文的文献

1
Bibliometric analysis combined with visualization on universal trends and hot topics of LOX family in human diseases: 1995 to 2025.1995年至2025年人类疾病中LOX家族的文献计量分析与普遍趋势及热点话题的可视化研究
Front Oncol. 2025 Jun 30;15:1601261. doi: 10.3389/fonc.2025.1601261. eCollection 2025.
2
A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer.催乳素与致癌性YAP-CCN2信号通路之间一种新型的临床相关拮抗相互作用,作为乳腺癌的一种分化治疗靶点。
Cell Death Dis. 2025 Mar 29;16(1):221. doi: 10.1038/s41419-025-07547-7.
3

本文引用的文献

1
Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer.胆囊癌中雌性激素受体、结缔组织生长因子和 HER2 的表达。
Sci Rep. 2020 Feb 5;10(1):1871. doi: 10.1038/s41598-020-58777-y.
2
Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) - Recommendations for Daily Routine Practice.三阴性乳腺癌(TNBC)的诊断与治疗——日常实践建议
Geburtshilfe Frauenheilkd. 2019 Jun;79(6):605-617. doi: 10.1055/a-0887-0285. Epub 2019 Jun 14.
3
YAP-independent mechanotransduction drives breast cancer progression.
Effect of palliative radiotherapy and cyclin-dependent kinase 4/6 inhibitor on breast cancer cell lines.
姑息性放疗和细胞周期蛋白依赖性激酶4/6抑制剂对乳腺癌细胞系的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 4. doi: 10.1007/s00210-025-03878-6.
4
Pan-cancer secreted proteome and skeletal muscle regulation: insight from a proteogenomic data-driven knowledge base.泛癌分泌蛋白质组与骨骼肌调节:来自蛋白质基因组数据驱动知识库的见解
Funct Integr Genomics. 2025 Jan 15;25(1):14. doi: 10.1007/s10142-024-01524-7.
5
SPARC: a potential target for functional nanomaterials and drugs.SPARC:功能性纳米材料和药物的潜在靶点。
Front Mol Biosci. 2023 Jul 28;10:1235428. doi: 10.3389/fmolb.2023.1235428. eCollection 2023.
6
FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer.FN1 介导的天冬氨酸代谢激活促进三阴性和腔 A 型乳腺癌的进展。
Breast Cancer Res Treat. 2023 Oct;201(3):515-533. doi: 10.1007/s10549-023-07032-9. Epub 2023 Jul 17.
7
Study on the Relationship Between Differentially Expressed Proteins in Breast Cancer and Lymph Node Metastasis.乳腺癌差异表达蛋白与淋巴结转移关系的研究
Adv Ther. 2023 Sep;40(9):4004-4023. doi: 10.1007/s12325-023-02588-w. Epub 2023 Jul 9.
8
High-throughput spatiotemporal monitoring of single-cell secretions via plasmonic microwell arrays.基于等离子体微腔阵列的高通量单细胞分泌物时空监测
Nat Biomed Eng. 2023 Jul;7(7):943-958. doi: 10.1038/s41551-023-01017-1. Epub 2023 Apr 3.
9
Cancer secretome: finding out hidden messages in extracellular secretions.癌症分泌组学:从细胞外分泌物中寻找隐藏的信息。
Clin Transl Oncol. 2023 May;25(5):1145-1155. doi: 10.1007/s12094-022-03027-y. Epub 2022 Dec 16.
10
Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.雌酮,主要的绝经后雌激素,与 ERa 结合诱导 SNAI2,上皮间质转化,以及 ER+乳腺癌转移。
Cell Rep. 2022 Nov 15;41(7):111672. doi: 10.1016/j.celrep.2022.111672.
YAP 非依赖性机械转导驱动乳腺癌进展。
Nat Commun. 2019 Apr 23;10(1):1848. doi: 10.1038/s41467-019-09755-0.
4
Enhancing cancer cell adhesion with clay nanoparticles for countering metastasis.利用粘土纳米颗粒增强癌细胞黏附力以对抗转移
Sci Rep. 2019 Apr 11;9(1):5935. doi: 10.1038/s41598-019-42498-y.
5
The PRIDE database and related tools and resources in 2019: improving support for quantification data.PRIDE 数据库及相关工具和资源在 2019 年的进展:提高定量数据支持。
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450. doi: 10.1093/nar/gky1106.
6
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率:GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
7
EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?肿瘤休眠与生长中的上皮-间质转化和干性:它们是相互交织的过程吗?
Front Oncol. 2018 Sep 12;8:381. doi: 10.3389/fonc.2018.00381. eCollection 2018.
8
Biophysics of Tumor Microenvironment and Cancer Metastasis - A Mini Review.肿瘤微环境与癌症转移的生物物理学——一篇综述短文
Comput Struct Biotechnol J. 2018 Jul 27;16:279-287. doi: 10.1016/j.csbj.2018.07.003. eCollection 2018.
9
Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy.在癌症治疗中靶向作用于细胞外信号调节激酶(ERK)——丝裂原活化蛋白激酶(MAPK)通路的致命弱点。
Acta Pharm Sin B. 2018 Jul;8(4):552-562. doi: 10.1016/j.apsb.2018.01.008. Epub 2018 Feb 16.
10
Autocrine Fibronectin Inhibits Breast Cancer Metastasis.自分泌纤维连接蛋白抑制乳腺癌转移。
Mol Cancer Res. 2018 Oct;16(10):1579-1589. doi: 10.1158/1541-7786.MCR-18-0151. Epub 2018 Jun 22.